Jonathan McNeill
Corporate Officer/Principal chez DYNE THERAPEUTICS, INC.
Fortune : 3 M $ au 30/04/2024
Profil
Jonathan McNeill is currently the Chief Business Officer at Dyne Therapeutics, Inc. Prior to his current position, he worked as the Associate Director-Business Development at Editas Medicine, Inc. from 2015 to 2019.
Dr. McNeill received his graduate degree from the University of Pennsylvania in 2014 and his undergraduate degree from The University of North Carolina at Chapel Hill in 2007.
He also holds a doctorate degree from Perelman School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
DYNE THERAPEUTICS INC
0,16% | 16/05/2024 | 136 634 ( 0,16% ) | 3 M $ | 30/04/2024 |
Postes actifs de Jonathan McNeill
| Sociétés | Poste | Début |
|---|---|---|
| DYNE THERAPEUTICS, INC. | Corporate Officer/Principal | 01/02/2019 |
Anciens postes connus de Jonathan McNeill
| Sociétés | Poste | Fin |
|---|---|---|
| EDITAS MEDICINE, INC. | Corporate Officer/Principal | 01/01/2019 |
Formation de Jonathan McNeill
| The University of North Carolina at Chapel Hill | Undergraduate Degree |
| University of Pennsylvania | Graduate Degree |
| Perelman School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| DYNE THERAPEUTICS, INC. | Health Technology |
| EDITAS MEDICINE, INC. | Health Technology |